Medical Center Enterprise Acute Care Hospital (Medicare Certified) Location: 400 N Edwards Street, Enterprise, Alabama 36330 Ratings: Phone: (334) 347-0584 |
News Archive
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.
Research by a team of scientists from Cologne, Munich and Mainz has shown an unprecedented degree of connectivity reorganization in newly-generated hippocampal neurons in response to experience, suggesting their direct contribution to the processing of complex information in the adult brain.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration had granted tentative approval of adenosine injection, USP, the generic equivalent of Astellas Pharmaceuticals' Adenoscan®, in 60 mg per 20 mL and 90 mg per 30 mL vials. IMS data indicate that the 2009 U.S. innovator market for these adenosine presentations approximated $124 million. The Company plans to launch the product upon expiry of applicable innovator patents.
Emerge Labs presents a revolutionary technology that protects skin stem cells and combats chronological aging. The breakthrough patent-pending active ingredient, PhytoCellTec Solar Vitis, boosts the production of human skin stem cells, protects human skin stem cells against UV radiation, and fights photo-aging, thus decreasing wrinkles and producing younger, fresher looking skin.
› Verified 3 days ago